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Abstract
Background: The prokaryotic FAD synthetase family – a group of bifunctional enzymes that
catalyse riboflavin phosphorylation and FMN adenylylation within a single polypeptide chain- was
analysed in terms of sequence and structure.
Results: Sequences of nearly 800 prokaryotic species were aligned. Those related with bifunctional
FAD synthetase activities showed conservation of several consensus regions and highly conserved
residues. A 3D model for the FAD synthetase from Corynebacterium ammoniagenes (CaFADS) was
generated. This model confirms that the N-terminal and C-terminal domains are related to
nucleotydyltransferases and riboflavin kinases, respectively. Models for the interaction of CaFADS
with its substrates were also produced, allowing location of all the protein substrates in their
putative binding pockets. These include two independent flavin binding sites for each CaFADS
activity.
Conclusion: For the first time, the putative presence of a flavin binding site for the adenylylation
activity, independent from that related with the phosphorylation activity, is shown. Additionally,
these models suggest the functional relevance of some residues putatively involved in the catalytic
processes. Their relevant roles were analysed by site-directed mutagenesis. A role was confirmed
for H28, H31, S164 and T165 in the stabilisation of the P groups and the adenine moiety of ATP
and, the P of FMN for the adenylylation. Similarly, T208, N210 and E268 appear critical for
accommodation of the P groups of ATP and the ribityl end of RF in the active site for the
phosphorylation process. Finally, the C-terminal domain was shown to catalyse the
phosphorylation process on its own, but no reaction at all was observed with the individually
expressed N-terminal domain.
Background
The activities of riboflavin (RF) phosphorylation and
FMN adenylylation are present among all kingdoms of
living organisms. However, whereas eukaryotes use two
different enzymes for FMN (flavokinase) and FAD (ade-
nylyltransferase) production [1-6], prokaryotic organisms
depend on an enzyme of ~38 kDa, FAD synthetase (Flavin
adenine dinucleotide synthetase, FADS), that exhibits
both activities [7]. Thus, FADS constitutes a bifunctional
prokaryotic protein family of enzymes with both, ATP:RF
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5'-phosphotransferase [Riboflavin kinase (RFK) (EC
2.7.1.26) (Flavokinase)] and ATP:FMN-adenylyltrans-
ferase [FMN adenylyltransferase (EC 2.7.7.2)] activities
[7,8] that catalyses the 5'-phosphorylation of RF to FMN
and, subsequently, the adenylylation of FMN to FAD.
RF phosphorylation RF + ATP → FMN + ADP
FMN adenylylation FMN + ATP → FAD + PPi
The FMN adenylylation reaction of FADS is a reversible
process, while phosphorylation of RF appears to be irre-
versible [9]. Additionally, FADS has been shown to func-
tion with a broad variety of RF isoesters, and it is,
therefore, widely used in the preparation of FMN and FAD
analogues [8,10]. A kinetic mechanism for the steady-state
reaction of the FADS from Corynebacterium ammoniagenes
(CaFADS) has been proposed [9], suggesting an order in
substrate binding and product release. The FMN interme-
diate produced by the first reaction appears to be released
by the enzyme to later rebind the enzyme as a substrate for
FAD production. Both enzyme activities present impor-
tant differences in their substrate requirements, including
concentration dependence, specificity for divalent cations
and optimal pH or temperature [7,11,12].
The C-terminal region of FADS (~150 residues) shares
considerably sequence similarity with eukaryotic mono-
functional RFKs. Likewise, the N-terminal region has been
proposed to present remote similarity to nucleotydyl-
transferases (NTs), suggesting its involvement in the ade-
nylylation process [13]. The structure of bifunctional
FADS has only been reported for the Thermotoga maritima
enzyme (TmFADS), both free and in complex with some
substrates [14,15]. This structure shows that the enzyme is
folded in two domains and it also confirms the presence
of one ATP-binding site in each of the domains and a sin-
gle flavin-binding site [14,15]. So far, neither functional
studies of the TmFADS nor FADS structures from any
other species have been reported.
A sequence analysis of the bifunctional FADS family and
an in silico structural model for the CaFADS are here pre-
sented. Based on these data, a preliminary functional
analysis of the CaFADS has been performed. Several resi-
dues are shown to be exclusively involved in either the
first or second catalytic event. Additionally, the C- and N-
terminal domains have been independently produced
and assayed for their activities. The structural information
here provided might help to envisage the rational design
of selective antimicrobial drugs with the function of
inhibiting FMN or FAD production and therefore, the
availability in the cell of enzymes depending on these
cofactors.
Methods
Sequence searches and alignments
The primary structure of CaFADS (sp|Q59263|RIBF_
CORAM) was obtained from the UniProtKB/SwissProt
database [12]. A SIB-BLAST search of the complete
CaFADS amino acid sequence was performed at http://
www.expasy.ch/tools/blast/[16] against the Eukaryota
and Bacteria+Archaea subsections of the non-redundant
data base UniProt Knowledgebase (Swiss-Prot + TrEMBL).
Multiple sequence alignment was generated using the
CLUSTAL W algorithm http://www.ebi.ac.uk/clustalw/
with default parameters [17]. Graphical representation of
the multiple sequence alignment was visualised using the
WebLogo server http://weblogo.berkeley.edu (Figure 1)
[18]. The sequence numbering used throughout the paper
corresponds to CaFADS.
Prediction of a three-dimensional model for the structure 
of FAD synthetase from C. ammoniagenes
The structural model for CaFADS was constructed using
homology modelling procedures based on multiple struc-
ture-base sequence alignments (including all the proteins
in the PDB) as implemented in the Geno3D Web server
[19]. This program uses distance geometry, simulated
annealing and energy minimisation algorithms to build
the protein models. The structural quality of the models
was checked using the PROCHECK validation program
[20]. The structures of TmFADS (1mrz, 1s4m, 1t6x, 1t6y)
[14,15] and those of RFKs from H. sapiens (1q9s, 1p4m)
[21,22] and S. pombe (1n06, 1n08) [23] were suitable as
templates. Six different combinations of templates were
used and three models were generated by each combina-
tion.
Prediction of substrate binding sites
Predictions of putative ATP, Mg2+ and FMN binding sites
of  CaFADS for FMN adenylylation at the N-terminal
domain were carried out by comparing our models with
the structures of the nicotinamide mononucleotide ade-
nylyltransferases (NMNAT) in complex with their sub-
strates (Table 1). Similarly, to model ATP, Mg2+ and RF
binding to the C-terminal domain of CaFADS, the struc-
tures of two RFKs in complex with their substrates (Table
1), as well as the different structures reported for TmFADS
bound to its different substrates (Table 1), were used. O
[24], Spdb-Viewer 3.7 [25] and PyMol 0.99 softwares [26]
were used for complex modelling, structural analysis and
figures production.
Cloning and production of C. ammoniagenes wild-type 
and mutated FAD synthetase forms in E. coli
Following the Ethical Rules established at the Universidad
de Zaragoza, strain DSM 20305 (ATCC 6872) from C.
ammoniagenes was grown at 30°C in a culture medium
containing 0.5% glucose, 0.5% NaCl, 1% tryptone andBMC Microbiology 2008, 8:160 http://www.biomedcentral.com/1471-2180/8/160
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0.5% yeast extract, pH 7.2–7.4. Genomic DNA was isolated
from the cells as previously described [27]. The CaFADS
encoding sequence was then amplified by the polymerase
chain reaction using the forward 5'-GTAAGCCATGGA-
TATTTGGTACGGAACAG-3' and reverse 5'-CCATCGAT-
AGCGGATCCGGCATATAC-3' primers, synthesised on the
basis of the published nucleotide sequence of the enzyme
[12]. The primers incorporate the NcoI  and  BamHI  sites
respectively, and have the transcription start codon GTG
replaced with ATG. The amplified 1237 bp DNA fragment
was then cloned in the NcoI/BamHI sites of the pET-28a(+)
expression vector. The resulting recombinant plasmid,
PET28a-FADS, was used to transform E. coli BL21(DE3) com-
petent cells. The transformants were selected on solid LB/agar
medium containing 30 μg/ml kanamicin. The fragment was
sequenced to confirm the accuracy of the amplification.
Mutations were introduced into the cloned structural gene
encoding the WT CaFADS by site-directed mutagenesis. The
H28A, H28D, H31A, H31D, R161A, R161D, S164A, S164D,
T165A, T165D, T208A, T208D, N210A, N210D, E268A and
E268D FADS mutants were generated using the QuikChange
mutagenesis kit (Stratagene) in combination with the ade-
quate synthetic oligonucleotides. The gene codifying for the
individual N-terminal domain (PET28a-Δ(183–338)FADS)
was obtained replacing the codon codifying for Leu183 in
PET28a-FADS with a stop codon, following the methodology
above mentioned for production of site-directed mutants.
The C-terminal domain was individually cloned (PET28a-
Δ(1–182)FADS) using the protocol described for WT
CaFADS with the forward primer 5'-CCAACTGGGCCAT-
GGGGCGGCAC-3' and the reverse primer above used for the
full length protein cloning. The forward primer used to clone
the C-terminal domain incorporates the start codon ATG
in a NcoI site substituting for Leu183. Mutations were ver-
Sequence logos including the bifunctional FADS family consensus regions and conserved residues Figure 1
Sequence logos including the bifunctional FADS family consensus regions and conserved residues. Numeration 
of CaFADS is used. The data of this logo is based on 500 sequences from the bacteria+archaea alignment of the FADS family. 
The sequence logo was produced using the WebLogo server http://weblogo.berkeley.edu[18].
21                   N1 32     49                          N2 65       70                       N3  108
187                                       C6 211 219           C7 227                  249                   C8 261
119                                N4 140                     161                                           N5 185
266                       C9 281                        290         C10 311 BMC Microbiology 2008, 8:160 http://www.biomedcentral.com/1471-2180/8/160
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ified by DNA sequence analysis. WT and mutant FADS
proteins were over-expressed in E. coli.
Purification of recombinant FADS from C. 
ammoniagenes
E. coli cells containing the recombinant pET28a-FADS
plasmid (or its mutants) were grown in LB. During the
exponential E. coli growing phase, FADS was induced by
overnight incubation at 37°C with IPTG (1 mM). Cells
were harvested by centrifugation and stored at -20°C. In a
typical purification, around 25 g of cells (over-expressing
recombinant FADS) were thawed, resuspended in 125 ml
of cell disruption buffer (50 mM Tris/HCl, pH 8.0, 1 mM
EDTA, 12 mM β-mercaptoethanol, 1 μM PMSF) and bro-
ken by ultrasonic treatment at 4°C using 16 cycles of 1
min in a DRH UP200 DR Hielsher sonicator. The cell
debris was removed by centrifugation at 40000 g during
45 min. The resulting yellow FADS-containing superna-
tant was fractioned with 45% ammonium sulphate. The
mixture was again centrifuged for 45 min at 4000 g and
the supernatant was loaded onto a Phenyl-Sepharose
High performance (Amersham Biosciences, GE Health-
care) column equilibrated with 50 mM Tris/HCl, pH 8.0,
45% ammonium sulphate. The column was washed with
the same buffer containing only 17% ammonium sul-
phate until most of the yellow colour washed out of the
column. The enzyme was eluted using a 17→0% ammo-
nium sulphate reversed-gradient in the same buffer. Frac-
tions of 6–8 ml were collected while the absorbance at
280 nm was recorded. Fractions presenting absorbance at
280 nm were analysed by SDS-PAGE and, those contain-
ing the over-expressed FADS were pooled and dialysed
against 50 mM Tris/HCl, pH 8.0. After dialysis the protein
was loaded onto a DEAE-cellulose (DE52, Whatman, Eng-
land) column equilibrated with 50 mM Tris/HCl, pH 8.0.
The column was washed with the equilibration buffer
containing 0.1 M NaCl and subsequently eluted using a
0.1→0.5 M NaCl gradient. Fractions of 5 ml were col-
lected while recording the absorbance at 280 nm and,
subsequently analysed by SDS-PAGE. The enzyme was
considered pure when a single band of the expected size
was observed in SDS-PAGE. Pure FADS fractions were
pooled together, dialysed against 50 mM Tris/HCl, pH 8.0
and stored at -20°C.
Measurement of riboflavin kinase and adenylyltransferase 
activities of FAD synthetase
Conversion of RF into FMN and, of FMN into FAD were
qualitatively assayed by addition of the different FADS
variants (final enzyme concentration ~1 μM, calculated
using a theoretical ε280 nm = 27.8 mM-1cm-1) to a solution
(final volume, 150 μl) containing 50 μM flavin (either RF
or FMN), 0.2 mM ATP and either 0.8 mM or 10 mM
MgCl2, in 50 mM Tris/HCl, pH 8.0. All these chemicals
Table 1: Structures used to model CaFADS and the interaction with its ligands. 
PDB SUBSTRATES (%) IDENTITIES (%) CONSERVATIVE SUBSTITUTIONS REFERENCE
FAD synthetases
T. maritima 1mrz 29.3 40.2 [14]
N-terminala 30.6 39.2
C-terminalb 27.6 41.5
T. maritima complexed
1s4m RF 29.3 40.2 [15]
1t6x ADP
1t6y FMN, ADP, AMP
Nucleotydyltransferasesa
GCT B. subtilis 1coz CTP 12.4 23.1 [30]
NMNAT M. jannaschii 1f9a Mg2+, ATP 12.9 22.0 [32]
NMNAT H. sapiens 1kku 10.8 18.3 [31]
NMNAT M. thermoautotropicum 1ej2 NAD+, Na+ 13.0 22.6 [33]
PPAT E. coli 1b6t dPCoA 13.0 26.3 [34]
1gn8 ATP, Mn2+ [37]
PPAT T. thermophilus 1od6 Ppant 11.3 22.0 [35]
Riboflavinkinasesb
H. sapiens 1p4m ADP, Mg2+, FMN 25.7 41.4 [21]
1q9s ADP, Mg2+, FMN [22]
1nb0 ADP, Mg2+ [21]
S. pombe 1n06 ADP [23]
1n07 FMN, ADP 23 38.2
1n08 Zn2+, ADP
Parameters derived from the structure-based sequence alignment of the produced CaFADS models over structural databases.
a Alignments with the segment 19–186 from CaFADS
b Alignments with the segment 187–338 from CaFADSBMC Microbiology 2008, 8:160 http://www.biomedcentral.com/1471-2180/8/160
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were obtained from SIGMA and were from the highest
purity available. After 30 minutes of incubation at 37°C,
the reaction was stopped by boiling the preparations for 5
minutes. Transformation of RF into FMN and FAD, or
FMN into FAD, was visualised by resolving the products of
the reaction at room temperature and in the dark by TLC
on Silica Gel SIL-G-25 (20 cm × 20 cm, thickness 0.25
mm) plates [28]. The moving phase was a solution of
butanol:acetic acid:water (12:3:5). Flavin TLC spots were
visually examined and scanned by determining their fluo-
rescence under an ultraviolet light. The different flavins
move up the plate at different rates due to differences in
their partioning behaviour between the mobile liquid
phase and the stationary phase. The weaker intensity of
the FAD fluorescence with regard to equivalent amounts
of RF or FMN relates with its flavin fluorescence quench-
ing upon stacking of the adenine portion [29]. An addi-
tional band, running slightly faster than FMN, is observed
in some experiments. The nature of this band is not
known, but it is only present in the experiments contain-
ing simultaneously FMN and FAD.
Results and discussion
Sequence analysis of the FAD synthetase family
No matches for bifunctional FADS sequences were
obtained when performing the SIB-BLAST search of the
CaFADS sequence on the UniProt Knowledgebase eukary-
ota subsection. When searching the bacteria+archaea
database subsection (2,929,087 sequences searched), the
777 sequences displaying E-values ≤ 0.009 were chosen
for further analysis. Redundant sequences from the same
species presenting sequence identity over 80% were elim-
inated. The remaining sequences included some proteins
noticeably shorter as well as proteins lacking the typical
consensus sequences found in FADSs. These sequences
(less than 5%), most of them displaying the lowest E-val-
ues of the selected sequences, were removed and sepa-
rately analysed. They could be sorted out into several
groups: i) proteins that present only the N-terminal region
of FADS, ii) proteins that present only the C-terminal
region of FADS, iii) proteins that lack the first conserved
motif in the N-terminal region, iv) proteins with a con-
served N-terminal region and a C-terminal region that
shares no similarity with the bifunctional FADS family,
and v) proteins with a conserved C-terminal region and a
N-terminal region that shares no similarity with the
bifunctional FADS family (in Rhodococcus sp. RHA1, the
protein N-terminal region is 40% identical to 3,4-dihy-
droxy-2-butanone-4-phosphate synthase, an enzyme
involved in RF biosynthesis). Some of these divergent pro-
teins belong to organisms that also possess a typical
prokaryotic FADS sequence.
After the manual refinement, a multiple sequence align-
ment over the remaining 500 FADS-like sequences, dis-
playing E-values ≤ 2xe-6 with CaFADS, was carried out.
Only FADSs from the genus Corynebacterium  displayed
sequence identities over 50% with the CaFADS (up to
60% identity in the case of the FADS from C. efficiens).
However, the multiple alignment pointed out several
highly conserved residues and motifs (Figure 1). Motifs
21-Φ-G-Ω-F-D-G-Φ-H-Ω-G-H-Ω-32 and 162-Φ-S-S-[TS]-
Ω-[IV]-R-Ω-Ω-Φ-Ω-Ψ-G-174 (Φ,  Ψ and Ω, denoting
hydrophobic, polar and any residue, respectively) (N1
and N5 in Figure 1) corresponded to two consensus
sequences in the FADS family that are also conserved in
NTs remotely related to FADS (see below). Two additional
consensus sequences in between the above mentioned
motifs were also observed. They included residues 50-Ω-
Φ-Φ-Ω-F-Ψ-P-[HQ]-P-Ω-59 and 120-Φ-Φ-Φ-G-Ω-[DN]-
[FYH]-Ω-[FY]-G-Ω-129 (N2 and N4 in Figure 1) and,
apparently, only the motif 123-G-Ω-Ψ-125 presents an
equivalent in NT sequences (see below). Multiple
sequence alignment also showed a number of residues
highly conserved, or conservatively substituted, between
residues 1 and 186: I71, R77, G85, I86, D87, F94, F98,
Y106, V107, A179, L183 and G184 (CaFADS numbering).
These residues are mainly included in region N3 and at
the end of N5 in Figure 1 and, can be considered as form-
ing additional consensus sequences. Noticeably, only R77
and A179 are conserved in NTs.
The C-terminal region of the bifunctional FADS sequences
(residues 187–338) also included several consensus
sequences, 191-G-Ω-V-Φ-Ψ-G-Ω-Ω-Ω-G-Ω-Ψ-Φ-203, 205-
G-[FY]-P-T-[ALIV]-N-210, 223-P-Ω-Ω-G-[VI]-[YF]-225,
253-Ψ-Φ-G-Ω-Ψ-P-T-[FVI]-260, 267-[LVI]-E-Ω-[HFYN]-Φ-
[FL]-[DN]-[FWY]-Ψ-Φ-[DNE]-[LIAV]-Y-[GDN]-280 and
291-[LI]-R-Ω-[EQMN]-Ω-[KRT]-[FY]-296, and the highly
conserved residues L303 and D310 (see C6–C10 in Figure
1), being all of them also conserved in the sequences of
RFKs (see below).
Structural model of the FAD synthetase from C. 
ammoniagenes
A 3D structural model for the CaFADS has been produced
based on the structure of the TmFADS (Figure 2) [14,15].
The low sequence similarity of the N-terminal domain of
FADSs with NTs prevented these enzymes to be used as
templates (Table 1, Figure 3A) [13], but the sequence sim-
ilarity found at the C-terminal domain of the FADS family
with RFKs from H. sapiens [21,22] and S. pombe (Table 1,
Figure 3B) [23] allowed them to be used as templates.
These RFKs were used for the construction of the model in
those loops were the X-ray structure of TmFADS did not
show experimental information [14,15]. Models for the
CaFADS C-terminal domain generated using as templates
only the structures of RFKs were consistent with the C-ter-
minal structure reported for TmFADS, indicating that
RFKs are a good choice as templates for this FADS familyBMC Microbiology 2008, 8:160 http://www.biomedcentral.com/1471-2180/8/160
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domain. Stereochemistry and energy analysis of the pro-
duced models suggested that the model constructed using
the FADS and RFK templates reported in Table 2 (Figure
2A) was adequate to describe the 3D structure of CaFADS
until structures are provided by experimental methods.
According to the model, the protein folds in two domains.
The N-terminal domain (residues 18–186) lacks the first
18 residues of the sequence (not present in the TmFADS
template), while the C-terminal domain (residues 187–
318) lacks the last 20 residues (templates were shorter in
sequence or presented very low sequence similarity in
those residues) (Figures 2 and 3). The main structural
arrangements predicted for the CaFADS are present in the
structure reported for the TmFADS [14,15], but our model
also showed the disposition of some loops and a 310-
helix at the C-terminal domain that are missed in the
TmFADS structure. Additionally, the C-terminal domain
of CaFADS showed an insertion around residue 230 with
regard to TmFADS and many members of the FADS fam-
ily.
The kinase domain: the C-terminal domain of C. 
ammoniagenes FAD synthetase
The C-terminal domain of the CaFADS model (residues
187–318) folds in a central six-stranded antiparallel β-
barrel stabilised between the single final α-helix (α7), the
two small α5 and α6 of the N-terminal domain and sev-
eral loops (Figure 2A). A short 310-helix is also predicted
in our model between residues G201-L204. This C-termi-
nal domain showed a high sequence identity in the 3D
space with the structures of the templates (Figures 3B and
4A, Table 1) and, there is no doubt that it must contribute
to ATP, Mg2+ and RF binding to produce FMN. Compari-
son of this model with the reported TmFADS and RFKs
structures in complex with their substrates will provide
information about CaFADS residues involved in substrate
binding and catalysis (Figures 3B and 4B). Therefore, it is
expected that the ADP-Mg2+, or ATP-Mg2+, will be nested
at one edge of the β-barrel, between two loops (Figure
4B). The first loop (R195-N210) contains the short 310-
helix and the 207-PTΦN-210 consensus sequence con-
served in RFKs (Figures 1 and 3B) and, it is proposed to
stabilise the P groups (Figure 4B). The structures of RFKs
in complex with ADP-Mg2+ also suggest that T208 and
N210 might contribute to metal binding [22,23]. The sec-
ond loop (E268-Y279) starts with the E268 residue, invar-
iant in FADS and RFK families and proposed to link the
terminal OH group of the RF ribityl chain, acting as a cat-
alytic base [21-23]. This loop also includes the D277 and
Y279 conserved positions, proposed to stabilise the ATP
adenine ring, while V193, K202 and D277 might contrib-
ute to stabilise the ribose (Figures 1 and 4B) by similarity
with RFKs [21,23]. Comparison of models with TmFADS
and RFKs complexed with RF or FMN suggests that the iso-
alloxazine ring must be bound in a pocket formed by the
outer surface of the β-barrel (β8–β10) and the long termi-
nal α7 helix. The flavin ring might result stabilised by the
hydrophobic environment provided by the consensus
region 223-G-V-Y-225 and the conserved F206, F270,
F297, L303 and M307 residues, while its hydrophilic por-
tion may be pointing towards the opening of the pocket
and stabilised by E295 or K296 [15,21,22]. Other residues
apparently not directly involved in flavin binding but con-
tributing to the formation of the bottom and top of the
pocket include the consensus region 254-G-Ω-Ψ-P-T-
[FVI]-260 and the highly conserved residues R292 and
D310, respectively. These two later residues apparently
form a salt bridge that contributes to fix the terminal α-
helix close to the top of the flavin ring cavity (Figure 4B).
The ribityl chain would extend towards β7, interacting as
above mentioned with E268 (Figure 4B).
The models for CaFADS suggest flexibility in the loops
connecting β6–β7 and β9–β10 (Figure 2B). Both of these
regions are not solved in the structures reported for the
TmFADS [14,15]. Flexibility is also observed in regions
involved in substrate binding (Figure 4B), in agreement
with conformational changes observed in RFKs upon sub-
strate interaction [22]. These conformational changes pro-
vide additional interactions, for both the ribityl tail and
the isoalloxazine ring and, help to anchor the reactive sub-
strates and the catalytic residues in the most adequate dis-
position for catalysis [21-23]. This analysis also suggests
that despite RFKs and FADSs surely share a similar mech-
anism in the RF phosphorylation reaction, variations in
the structural details for substrate binding and catalysis
can be expected.
Table 2: R.m.s.d. (Å) between the three predicted models for CaFADS and the structures used for their production.
Structure Model 1 Model 2 Model 3
Model 1 0.00 1.34 1.49
Model 2 1.34 0.00 1.22
Model 3 1.49 1.22 0.00
T. maritima FADS (1mrz) 1.53 1.49 1.44
T. maritima FADS, RF (1s4m) 1.60 1.56 1.39
H. sapiens RFK, ADP, Mg2+, FMN (1p4m) 1.74 1.54 1.25
S. pombe RFK, ADP, Zn2+ (1n08) 1.82 1.67 1.60BMC Microbiology 2008, 8:160 http://www.biomedcentral.com/1471-2180/8/160
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The adenylyltransferase domain: the N-terminal domain 
of C. ammoniagenes FAD synthetase
The CaFADS N-terminal domain consists of a classical α/
β dinucleotide binding domain. Its core is formed by a
twisted five-stranded parallel β-sheet flanked by two long
and two short α-helices and the corresponding connect-
ing loops (Figure 5). The end of this domain forms a small
subdomain made up of two small α-helices (α5 and α6),
which are in contact with the C-terminal domain. The
CaFADS model was compared with the structures
reported for several enzymes of the NT α/β phosphodi-
esterase superfamily (Table 1, Figures 3A and 5A), either
free or in complex with their substrates [13-15,30-35].
Members of this family catalyse the transfer of a nucle-
otide monophosphate moiety, from a nucleotide triphos-
phate (NTP), onto different substrates. Our CaFADS N-
terminal model presents an overall folding conserved in
NTs (Figure 5A) that allowed improvement of the
sequence alignments and production of putative models
for the interaction between this CaFADS domain and its
substrates (Figures 3A, 5 and 6). The consensus regions
19–32 and 162–174, highly conserved in the FADS and
NT families (Figures 1 and 3A), are proposed to be
involved in NTP stabilisation in the active site. In our
model these motifs include the α1 helix (H28-V45),
placed between β1 and β5, the E158-S164 loop and some
portions of the two terminal antiparallel α-helices, (α5
(T165-S172) and α6 (D175-L183)) (Figure 5). Residues
of these consensus regions show a high conservation in
primary and 3D structures when comparing the FADS and
NT families. Thus, in CaFADS: i) main-chain atoms of
G22, F24 and D25 might H-bond the α-P of ATP, ii) H28,
G30 and H31 (N-terminal of helix α1) might contribute
to stabilise the P groups and adenine moiety of ATP, iii)
Predicted structural model for CaFADS Figure 2
Predicted structural model for CaFADS. (A) Ribbon representations of the model selected to represent CaFADS (Table 
2). (B) Superposition of the three models generated in this prediction. Residues involved in putatively high flexible regions are 
indicated.
A
N-terminal
C-terminal
B
111-119
55-67
85-97
195-209
249-264BMC Microbiology 2008, 8:160 http://www.biomedcentral.com/1471-2180/8/160
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Figure 3 (see legend on next page)
 
A. N-terminal alignment 
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B. C-terminal alignment 
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the ATP P groups might interact with L34, T38, I162,
G174 and the 104–106 and 153–157 regions, iv) the con-
sensus region 162–165 (including the N-terminals of α5)
must be involved in stabilisation of the adenine, β-P and
γ-P of ATP and, v) the 123–125 consensus motif accom-
modates the ribose portion of the nucleotide (Figures 3A
and 5), as proposed for the equivalent residues in
TmFADS, glycerol-3 phosphate cytidylyltransferase
(GCT), phosphopantetheine adenylyltransferase (PPAT)
and NMNAT (Figure 3A, 5A) [31,32,34]. The loop formed
by residues 156–160 (in red in Figure 5B), although con-
served in sequence and structure, shows different orienta-
tions and lengths in the different NTs, which probably
determines the enzyme specificity for the NTP (Figures 3A
and 5A) [30]. The CaFADS model also showed several
positively charged side-chains highly conserved in the
FADS family and structurally situated in positions also
occupied by positively charged side-chains in NT struc-
tures. These include R161 and R168 (R161 provided by
R91 and R22 in PPAT from E. coli or T. thermophilus and,
R168 by K46 in B. subtilis GCT or R47 in M. thermoau-
totrophicum NMNAT). Their positions suggest that these
side-chains might contribute to stabilise the adenine and
P groups of ATP when bound to the active site. It is also
worth noting that an important number positions occu-
pied by conserved glycines in the FADS family are also
conserved in sequence and structure in NTs and, in many
cases, their main-chain atoms directly provide H-bonding
to the nucleotide (Figures 1 and 3A).
Flexible regions can be predicted by comparison of the
CaFADS models (Figure 2B, Table 2). These, including
55–67, 85–97, 111–119 and 127–135, correspond to low
similarity regions between NT and FADS families (Figures
2B, 3A and 5A). Structures of NMNAT in complex with
NAD+ [33], and PPAT in complex with dPCoA [34] or
Ppant [35], indicate that the binding of the adenylylation
substrate, NMN+ or Ppant moieties, is allocated in the
pocket formed by the above mentioned regions. Superpo-
sition of these complexes on our CaFADS model, fol-
lowed by fitting and sculpting the FMN molecule along
the nicotinamide nucleotide moiety of NAD+  in the
NMNAT structure, allowed production of putative models
for the interaction of the FADS N-terminal domain with
its FMN substrate (Figure 6A). In this model, the FMN iso-
alloxazine ring would be placed in a cavity surrounded by
the above mentioned flexible regions. The entrance of this
cavity would be flanked by the F54, F62 and D94 hydro-
phobic side-chains, the consensus region 54-FPHP-58
would fix the position of the ribityl of FMN, while the fla-
vin ring environment would be contributed by hydropho-
bic interactions with V59, L98, Y106 and F128 (Figure
6A). All these positions are highly conserved in the FADS
family, but do not have equivalence in NTs (Figures 1 and
3A). The model suggests that the hydrophobic iso-
alloxazine portion of the flavin ring might be embedded
inside the cavity, while the hydrophilic edge would be
partially exposed to the solvent. The size of the cavity
makes it difficult to predict the precise location of the iso-
alloxazine ring. Various possibilities are allowed (Figure
6A) and, final disposition of loops and side-chains would
depend on the flavin binding event and conformational
changes not predicted in our model. This flavin binding
mode could represent a novel flavin binding motif so far
not described. Additionally, while sequence motifs N1,
N4 and N5 are also conserved in the sequences of eukary-
otic FMN adenylyltransferases, residues and regions pro-
posed for flavin binding in the FADS family do not
present homologous in the sequences of the monofunc-
tional enzymes (data not shown).
This is the first structural model where a putative binding
site for the flavin is suggested at the adenylylation site of
FADS, indicating the presence of two independent flavin
binding sites in the FADS family. An early hypothetical
model for the active site of FADS proposed a single flavin
binding site for both activities and two independent ATP
binding sites [9]. No structural information of this family
of enzymes was reported at that time, but that model
accounted for the kinetic mechanism experimentally
derived [9]. The 3D structures and models today available
for FADS indicate that the phosphorylation and adeny-
Alignments Figure 3 (see previous page)
Alignments. (A) Structural alignment of the N-terminal domain of the CaFADS model (residues 19–186) with the corre-
sponding regions of TmFADS and several NTs. Residues proposed to be involved in particular substrate binding are marked as; 
● for phosphate groups, ✳ ribose or ▲ adenine portions of ATP. Ќ denotes regions where substrates specific for each 
enzyme have been reported to interact. (B) Structural alignment of the C-terminal domain (residues 187–338) of the C. ammo-
niagenes FADS model with those of TmFADS and RFKs from S. pombe and H. sapiens. Residues proposed to be involved in par-
ticular substrate binding are marked as; ● for phosphate groups, ✳ ribose or ▲ adenine portions of ATP and,  for the 
phosphate, Ќ ribityl or ■ isoalloxazine ring portions of RF. Each template is referred to its pdb code according to Table 1. 
Residues involved in substrate binding in each particular structure are shown in bold case. Consensus sequences are shown 
below alignment, Φ, Ψ and Ω denoting hydrophobic, polar and any residue, respectively. Secondary structure prediction of 
CaFADS, obtained using the JOY server [36] and visual inspection, is shown above each alignment, with β signifying β-strand 
residues and α signifying α-helix residues.BMC Microbiology 2008, 8:160 http://www.biomedcentral.com/1471-2180/8/160
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C-terminal domain structure of CaFADS Figure 4
C-terminal domain structure ofCaFADS. (A) Comparison of the structural elements with those found in RFKs. (B) 
Model for the interaction of ADP-Mg2+ and RF with the C-terminal domain. Residues putatively involved at the RFK active site, 
nucleotides and flavins are shown in CPK sticks. Carbon atoms are shown in green, white and orange for protein side-chains, 
nucleotides and RF, respectively. Mg2+ ions are shown as yellow balls.
B
A
1p4m (ADP, FMN, Mg2+)                           1n07 (ADP, FMN)
FADS C. ammoniagenes 1t6y (ADP, FMN) 
α7
β11
310
β8
β9
β6
β7
β10
RFBMC Microbiology 2008, 8:160 http://www.biomedcentral.com/1471-2180/8/160
Page 11 of 16
(page number not for citation purposes)
N-terminal domain structure of CaFADS Figure 5
N-terminal domain structure of CaFADS. (A) Comparison of the structural elements with those found in NTs. (B) 
Model for the interaction of ATP-Mg2+ with the N-terminal domain. Residues putatively involved in the NT activity and ATP 
binding are drawn as sticks and CPK coloured. Carbon atoms are shown in green and white, for the protein side-chains and 
nucleotides, respectively. Mg2+ and Na+ ions are shown as yellow and red balls, respectively.
B
α1
α5
α6
α2
α3
α4
β1
β2
β3
β4
β5
1f9a (ATP, Mg2+) 1ej2 (NAD+, Na+, SO4
2-) 1b6t (dPCoA) 
A
FADS C. ammoniagenes 1t6y (AMP)                           1coz (CTP)BMC Microbiology 2008, 8:160 http://www.biomedcentral.com/1471-2180/8/160
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Localisation of the flavin binding site at the N-terminal domain of CaFADS Figure 6
Localisation of the flavin binding site at the N-terminal domain of CaFADS. (A) Models for the interaction of FMN 
with the N-terminal domain. FMN and residues putatively involved in its stabilisation are drawn in sticks and CPK coloured. 
Two possible conformations for the FMN are indicated (Carbon atoms are in orange and blue, respectively). Positions of ATP 
and Mg2+ are also indicated as pink lines and a yellow ball, respectively. (B) Model for the interaction between two CaFADS 
monomers (grey lines), based on the TmFADS crystallographic dimeric crystal unit. The C-terminal of monomer 1 is shown in 
green and the N-terminal of monomer 2 in blue. Position of the RF and FMN substrates, as well as ATP-Mg2+, are indicated at 
each binding site in CPK. Carbon atoms are shown in white and orange for nucleotides and flavins, respectively. H28 and H31 
are shown as sticks.
B
ABMC Microbiology 2008, 8:160 http://www.biomedcentral.com/1471-2180/8/160
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lylation sites are far away (Figure 6B). This fact is in agree-
ment with experimental observations indicating that the
FMN produced in the phosphorylation process was
released from the protein, to subsequently rebind to initi-
ate the adenylylation process [9]. Superposition of our
CaFADS model in complex with all its substrates with the
dimer reported in the TmFADS crystallographic asymmet-
ric unit also indicates that phosphorylation and adeny-
lylation active sites from different monomers are far away
to share the FMN molecule. However, this dimeric model
suggests that the 229–243 loop and the terminal α7 of the
C-terminal domain might contribute to the formation of
the ATP and the flavin binding pockets in the adenylyla-
tion domain (Figure 6B).
Production of C. ammoniagenes FAD synthetase forms
E. coli BL21(DE3) cells transformed with the recombinant
PET28a-FADS vector produced a high level expression of
active  CaFADS. This CaFADS was purified in complex
with one of the products of its reaction, FAD, as confirmed
by HPLC (data not shown). To remove the FAD a hydro-
phobic chromatography was required. The sequence and
structural analysis suggested the presence of several resi-
dues and motifs in CaFADS highly conserved in this fam-
ily of enzymes and potentially involved in the Catalytic
sites of the RFK and NT activities. Some of these residues
were mutated, namely H28, H31, R161, S164, T165,
T208, N210 and E268 to Ala and Asp. These CaFADS var-
iants were expressed in E. coli, with yields similar to the
WT FADS, and were purified to homogeneity following
the same protocol. Additionally, plasmids individually
expressing the N-terminal and C-terminal CaFADS
domains were also produced, PET28a-Δ(183–338)FADS
and PET28a-Δ(1–182)FADS, respectively, and trans-
formed in E. coli, showing a level of expression similar to
the full length protein.
C. ammoniagenes FAD synthetase residues involved in 
FMN and FAD production
The ability of the different individual CaFADS mutants to
catalyse conversion of RF into FMN and of FMN into FAD
was analysed by incubating the same amount of each
mutant with the substrates of both enzyme activities.
Reactions were carried out under two different Mg2+ con-
centrations; one favouring the RFK activity (0.8 mM) and
the other favouring the NT activity (10 mM) [7,11,12].
However, both concentrations produced similar qualita-
tive results under the assayed conditions. The products of
the reactions were analysed by TLC (Figure 7).
Replacement of H28 with either Ala or Asp and H31 with
Ala prevented conversion of FMN into FAD, confirming
their implication in the CaFADS NT activity. Both of these
His residues belong to a consensus region 27-Φ-H-Ω-G-H-
Ω-32 found both in FADS and NT families (Figure 1 and
3A). Therefore, H28 and H31 will surely be major deter-
minants in the stabilisation of the P groups and the ade-
nine moiety of ATP in the reaction transition state in
CaFADS, in agreement with previous observations in NTs
[31,32,34]. Replacement of H28 with Ala also prevented
the conversion of RF into FMN, pointing to a possible
Resolution by thin layer chromatography of the products of  the RFK and the NT activities of selected CaFADS variants Figure 7
Resolution by thin layer chromatography of the prod-
ucts of the RFK and the NT activities of selected 
CaFADS variants. The reaction mixtures contained: (A), 
2-WT and 50 μM RF, 3-H28D and 50 μM RF, 4-R161D and 
50 μM RF, 5-S164D and 50 μM RF, 6-T208A and 50 μM RF, 
7-T208A and 50 μM FMN and 8-E268D and 50 μM RF. (B), 
2-WT CaFADS and 50 μM RF, 3-CaFADS C-terminal domain 
and 50 μM RF, 4-CaFADS C-terminal domain and 50 μM 
FMN and 5-a reaction mixture containing RF incubated in the 
absence of enzyme. Lanes (1) in (A) and (B) corresponded to 
a standard solution containing 50 μM RF, 50 μM FMN and 50 
μM FAD. All the reaction mixtures contained 0.2 mM ATP 
and 10 mM MgCl2 in 50 mM Tris/HCl, pH 8.0. Experiments in 
(A) were carried out with pure CaFADS variants at concen-
tration 1 μM, while reaction mixtures in (B) contained crude 
extracts with the over-expressed CaFADS C-terminal 
domain. (C) Product formation in the assayed samples. X, T 
and hyphen indicate production, detection of only traces and 
no production of the corresponding reaction product, 
respectively.
1         2      3       4      5     6       7       8     
RF
FMN
FAD
A
1      2     3    4     5
RF
FMN
FAD
B
C  
Substrate  RF    FMN      RF     FMN  
Product  FMN  FAD    FAD      FMN  FAD    FAD 
FADS            FADS         
WT  X  X    X    T208A  -  -    X 
H28A  -  -    -    T208D  -  -    X 
H28D  X  -    -    N210A  -  -    X 
H31D  X  X    X    N210D  -  -    X 
R161A  X  X    X    E268A  -  -    X 
R161D  X  X    X    E268D  -  T    X 
S164A  X  X    X    Δ(1-182)  X  -    - 
S164D  X  -    X    Δ(183-338)  -  -    - 
T165A  X  X    X    Δ(1-182)+Δ(183-338)  X  -    - 
T165D  X  -    -             BMC Microbiology 2008, 8:160 http://www.biomedcentral.com/1471-2180/8/160
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influence of the N-terminal domain in the RFK activity.
His28 appears situated at the N-terminal of α1, in contact
with α5 and α6, which, according to our model, will inter-
act with the C-terminal domain from the same polypep-
tide chain, but also might influence the C-terminal of the
second monomer in a putative dimeric structure (Figure
6B). However, it is difficult to envisage how the H28A
mutation might affect the phosphorylation reaction with
the available information. This will need further structural
and biochemical characterisation. Replacement of H31
with Asp produced an enzyme still able to produce FMN
and FAD, suggesting that an Asp at this position some-
what replaces the function of the His. Replacements were
also introduced in the second major consensus sequence
shared by the FADS and the NT families, 162-ΦSST-165.
Replacement of S164 or T165 with Ala produced enzyme
forms able to transform RF into FMN and FMN into FAD,
while the introduction of a Asp residue at such positions
clearly prevented FAD formation. This latter observation
was consistent with these residues being involved in the
stabilisation at the NT catalytic site of the negatively
charged β-P and γ-P of ATP or the ribityl end, as suggested
by the above structural analysis (Figures 3A and 5B).
Finally, the putative role of the structural disposition of
the positive charge of R161 in the stabilisation of the ade-
nine and α-P and β-P of ATP in the active site was studied
by replacement of R161 with either Ala or Asp. The pro-
duced FADS mutants were still able to produce FMN and
FAD under the assayed conditions, suggesting the positive
charge at position of R161 is not playing a critical role in
CaFADS catalysis.
Taking into account the fact that T208, N210, and E268
are conserved in sequence and structural position in the
close environment of the ATP, not only in the FADS fam-
ily but also in RFKs, and that the terminal oxygen of the
ribityl of RF binding sites (Figures 1, 3B and 4), a catalytic
role for them in the RF phosphorylation process can be
envisaged. These CaFADS residues were replaced with Ala
or Asp to prove such a role. All these mutations prevented
FMN production, but allowed transformation of FMN
into FAD, confirming their implication in the RFK activity
of FADS. These data are, therefore, in agreement with the
proposed structural-based role for T208 and N210 in
accommodating the active portion of the ATP molecule,
the P groups, and the metal in the catalytic centre (Figure
4B). The lack of FMN and FAD production when replacing
E268 with Ala confirms it is a key residue in the CaFADS
RFK activity. Analysis of the interaction of the CaFADS
model with FMN (or RF) also indicated that in CaFADS
E268 side-chain might H-bond to the terminal OH of the
ribityl chain of RF (Figure 4B). This Glu is invariant in the
FADSs and RFKs families (Figures 1 and 3B). In this later
family this residue has been proposed to act as a catalytic
base [21-23]. Moreover, the fact that incubation of E268D
with RF did not produce any accumulation of FMN, while
traces of FAD were detected, is consistent with the RFK
activity taking place at a very slow rate in this mutant, thus
avoiding FMN accumulation. This suggests that although
the introduced mutation is conservative and the Asp side-
chain might still act as a base, its shorter side-chain pre-
vents the optimal organisation of the transition state in
the active centre and, therefore, reduces the catalytic effi-
ciency of the RFK activity. Again, this is consistent with
this residue not presenting substitutions, even conserva-
tive ones, in the analysed proteins. Nevertheless, other
explanations might be also possible, as higher catalytic
efficiency of NT activity than that of RFK or sensitivity of
the TLC analysis. Further work should be done by the
analysis of the kinetic parameters for both activities, as
well as of the interaction parameters for the different sub-
strates, for all these CaFADS mutants to provide addi-
tional insights in their specific role in the enzyme catalytic
mechanisms.
Activity of the independently produced C. ammoniagenes 
FAD synthetase N- and C- terminal domains
Crude extracts of the E. coli cells expressing the individu-
ally cloned N-terminal and C-terminal domains of
CaFADS, Δ(183–338)FADS and Δ(1–182)FADS, respec-
tively, were prepared and assayed for NT and RFK activi-
ties (Figures 7B, 7C). Analysis of the products of the
reaction by TLC concluded that the C-terminal domain,
Δ(1–182)FADS, was able to qualitatively catalyse the
phosphorylation process. However, crude extracts over-
expressing the N-terminal domain, Δ(183–338)FADS,
were not able to catalyse the conversion of FMN into FAD.
Extracts containing both domains were mixed and
assayed for both reactions. Conversion of RF into FMN
was produced in these samples, but they were not able to
mimic CaFADS in the adenylylation process. This is in
agreement with a possible C-terminal domain role in con-
tributing to the stabilisation of the flavin and ATP sub-
strates in the corresponding N-terminal domain pockets
(Figure 6B).
Conclusion
A sequence analysis has been carried out in the bifunc-
tional FADS family. An important number of consensus
regions and conserved residues have been determined,
despite the low sequence identity among members of this
family. Sequence divergences found among pathogenic
organisms, such as Mycobacterium or Corynebacterium, and
monofunctional eukaryotic enzymes will probably be
reflected in structural divergences that might affect the cat-
alytic mechanism, making possible the design of specific
antimicrobial drugs. Models have been proposed, not
only for the CaFADS structure, but also for the complexes
formed with all its substrates. This includes de interaction
with the FMN substrate at the adenylylation site, in aBMC Microbiology 2008, 8:160 http://www.biomedcentral.com/1471-2180/8/160
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region not previously reported as involved in the enzyme
activity and, in a pocket that might constitute a novel fla-
vin binding motif. As expected, these models supported
that the N-terminal presents similar folding to NTs and is
involved in the adenylylation of FMN, whereas the C-ter-
minal is similar to RFKs and responsible for the phospho-
rylation. Models of CaFADS allowed identification of
several residues putatively involved in the catalysis. Site-
directed mutagenesis on some of these residues confirmed
their participation in substrate stabilisation and/or the
catalytic mechanism. The particular behaviour of some of
these mutants and of the independently expressed NT and
RFK domains suggests one of the domains might influ-
ence the activity in the other one. This study sheds impor-
tant and new information on the structural mechanism of
substrate recognition and catalysis while waiting for the
experimental structure of the CaFADS and provides a plat-
form for future investigations into the mechanism of
enzymes of the bifunctional FADS family.
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